These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33575433)

  • 21. Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes.
    Hong ES; Lim C; Choi HY; Lee YK; Ku EJ; Moon JH; Park KS; Jang HC; Choi SH
    BMJ Open Diabetes Res Care; 2019; 7(1):e000776. PubMed ID: 31798902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
    Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
    Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methionine restriction prevents onset of type 2 diabetes in NZO mice.
    Castaño-Martinez T; Schumacher F; Schumacher S; Kochlik B; Weber D; Grune T; Biemann R; McCann A; Abraham K; Weikert C; Kleuser B; Schürmann A; Laeger T
    FASEB J; 2019 Jun; 33(6):7092-7102. PubMed ID: 30841758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding the Physiology of FGF21.
    Fisher FM; Maratos-Flier E
    Annu Rev Physiol; 2016; 78():223-41. PubMed ID: 26654352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis.
    Herrero-Cervera A; Vinué Á; Burks DJ; González-Navarro H
    Diabetologia; 2019 Nov; 62(11):2143-2157. PubMed ID: 31388695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction in serum fibroblast growth factor-21 after gastric bypass is related to changes in hepatic fat content.
    Fjeldborg K; Pedersen SB; Møller HJ; Richelsen B
    Surg Obes Relat Dis; 2017 Sep; 13(9):1515-1523. PubMed ID: 28552744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast growth factor-21 (FGF21) administration to early-lactating dairy cows. II. Pharmacokinetics, whole-animal performance, and lipid metabolism.
    Caixeta LS; Giesy SL; Krumm CS; Perfield JW; Butterfield A; Boisclair YR
    J Dairy Sci; 2019 Dec; 102(12):11597-11608. PubMed ID: 31548064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice.
    Gong Q; Hu Z; Zhang F; Cui A; Chen X; Jiang H; Gao J; Chen X; Han Y; Liang Q; Ye D; Shi L; Chin YE; Wang Y; Xiao H; Guo F; Liu Y; Zang M; Xu A; Li Y
    Hepatology; 2016 Aug; 64(2):425-38. PubMed ID: 26926384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis.
    Park JG; Xu X; Cho S; Hur KY; Lee MS; Kersten S; Lee AH
    Sci Rep; 2016 Jun; 6():27938. PubMed ID: 27301791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A low-protein diet induces body weight loss and browning of subcutaneous white adipose tissue through enhanced expression of hepatic fibroblast growth factor 21 (FGF21).
    Pérez-Martí A; Garcia-Guasch M; Tresserra-Rimbau A; Carrilho-Do-Rosário A; Estruch R; Salas-Salvadó J; Martínez-González MÁ; Lamuela-Raventós R; Marrero PF; Haro D; Relat J
    Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28078804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGF21 mediates alcohol-induced adipose tissue lipolysis by activation of systemic release of catecholamine in mice.
    Zhao C; Liu Y; Xiao J; Liu L; Chen S; Mohammadi M; McClain CJ; Li X; Feng W
    J Lipid Res; 2015 Aug; 56(8):1481-91. PubMed ID: 26092866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
    Iglesias P; Selgas R; Romero S; Díez JJ
    Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary Methionine Restriction Reduces Inflammation Independent of FGF21 Action.
    Sharma S; Dixon T; Jung S; Graff EC; Forney LA; Gettys TW; Wanders D
    Obesity (Silver Spring); 2019 Aug; 27(8):1305-1313. PubMed ID: 31207147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroblast growth factor-21, energy balance and obesity.
    Giralt M; Gavaldà-Navarro A; Villarroya F
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():66-73. PubMed ID: 26415590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
    Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
    Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-adrenergic receptors are critical for weight loss but not for other metabolic adaptations to the consumption of a ketogenic diet in male mice.
    Douris N; Desai BN; Fisher FM; Cisu T; Fowler AJ; Zarebidaki E; Nguyen NLT; Morgan DA; Bartness TJ; Rahmouni K; Flier JS; Maratos-Flier E
    Mol Metab; 2017 Aug; 6(8):854-862. PubMed ID: 28752049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of hepatic fibroblast growth factor 21 as a mediator in 17β-estradiol-induced white adipose tissue browning.
    Hua L; Zhuo Y; Jiang D; Li J; Huang X; Zhu Y; Li Z; Yan L; Jin C; Jiang X; Che L; Fang Z; Lin Y; Xu S; Li J; Feng B; Wu D
    FASEB J; 2018 Oct; 32(10):5602-5611. PubMed ID: 29718710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient mice.
    Fletcher JA; Linden MA; Sheldon RD; Meers GM; Morris EM; Butterfield A; Perfield JW; Rector RS; Thyfault JP
    Exp Physiol; 2018 Mar; 103(3):408-418. PubMed ID: 29215172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise Alleviates Obesity-Induced Metabolic Dysfunction via Enhancing FGF21 Sensitivity in Adipose Tissues.
    Geng L; Liao B; Jin L; Huang Z; Triggle CR; Ding H; Zhang J; Huang Y; Lin Z; Xu A
    Cell Rep; 2019 Mar; 26(10):2738-2752.e4. PubMed ID: 30840894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AAV-mediated BMP7 gene therapy counteracts insulin resistance and obesity.
    Casana E; Jimenez V; Jambrina C; Sacristan V; Muñoz S; Rodo J; Grass I; Garcia M; Mallol C; León X; Casellas A; Sánchez V; Franckhauser S; Ferré T; Marcó S; Bosch F
    Mol Ther Methods Clin Dev; 2022 Jun; 25():190-204. PubMed ID: 35434177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.